Long-term protection of hepatitis B vaccine: Lessons from Alaskan experience after 15 years

Annals of Internal Medicine

Volumn 142, Issue 5, 2005, Pages 384-385

  Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

AGE DETERMINATION; DISEASE COURSE; FOLLOW UP; GENDER; HEPATITIS; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INFECTION CONTROL; LIVER CELL CARCINOMA; LIVER DISEASE; LONG TERM CARE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; UNITED STATES; VACCINATION; VIRUS TRANSMISSION;

EID: 14344249449     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-5-200503010-00014     Document Type: Review

References (20)

1. Margolis HS. Hepatitis B virus infection. Bull World Health Organ. 1998;76 Suppl 2:152-3.
2. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395-403.
3. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993;262:369-70.
4. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-45.
5. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med. 2004;350:1118-29.
6. Chen DS. Viral hepatitis in East Asia. J Formos Med Assoc. 1996;95:6-12.
7. Heyward WL, Bender TR, McMahon BJ, Hall DB, Francis DP, Lanier AP, et al. The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions. Am J Epidemiol. 1985;121:914-23.
8. Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, Kuo YT, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA. 1987;257:2597-603.
9. Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G, et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis. 2000;181:413-8.
10. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med. 2001;135:796-800.
11. Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr. 2001;139:349-52.
12. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336:1855-9.
13. West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine. 1996;14:1019-27.
14. Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine. 2000;19:877-85.
15. Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, et al. Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine. 1999;17:2661-6.
16. Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis. 2003;187:134-8.
17. Yuan MF, Lim WL, Chan AO, Wong DK, Sun SS, Lai CL. 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. Clinical Gastroenterology and Hepatology. 2004;2:941-5.
18. Boxall EH, Sira JA, El-Shuhkri N, Kelly DA. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis. 2004;190:1264-9.
19. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005;142:333-41.
20. Kane M. Global programme for control of hepatitis B infection. Vaccine. 1995;13 Suppl 1:S47-9.